Estrogen receptor action

Critical Reviews in Eukaryotic Gene Expression

Volumn 12, Issue 4, 2002, Pages 237-257

  Nilsson, Stefan ^a   Gustafsson, Jan Åke ^b  

^a Karo Bio   (Sweden)

^b Department of Medical Nutrition ^*  (Sweden)

Author keywords

Cofactor; Mechanism; Peptide; Phage display; SERM; Structure

Indexed keywords

AMINO ACID; ANTIESTROGEN; BUTYRIC ACID; CELL NUCLEUS RECEPTOR; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GENISTEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HYBRID PROTEIN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYTOCIN; PROTEIN; PROTEINASE; RECEPTOR PROTEIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; TAMOXIFEN; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; TRICHOSTATIN A; UNINDEXED DRUG; VITELLOGENIN;

AMINO TERMINAL SEQUENCE; CIRCULAR DICHROISM; CRYSTALLOGRAPHY; DNA BINDING; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIGAND BINDING; MASS SPECTROMETRY; MEMBRANE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; STOICHIOMETRY; TRANSCRIPTION INITIATION;

ANIMALS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 0041860848     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukaryotGeneExpr.v12.i4.10     Document Type: Review

References (154)

1. Aronica SM, Kraus WL, Katzenellenbogen BS (1994): Estrogen action via cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521.
2. Bain DL, Franden MA, McManaman JL, Takimoto GS, Horwitz KB (2000): The N-terminal region of the human progesterone A-receptor. Structural analysis and the influence of the DNA binding domain. J Biol Chem 275:7313-7320.
3. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J-Å, Nilsson S (1998): Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol Pharmacol 54:105-112.
4. Batistuzzo de Medeiros SR, Krey G, Hihi AK, Wahli W (1997): Functional interaction between the estrogen receptor and the transcription activator Sp1 regulates the estrogen-dependent transcriptional activity of the vitellogenin A1 promoter. J Biol Chem 272:18250-18260.
5. Beato M (1989): Gene regulation by steroid hormones. Cell 56:335-344.
6. Beato M, Klug J (2000): Steroid hormone receptors: an update. Human Reprod Update 6:225-236.
7. Beekman JM, Allan GF, Tsai SY, Tsai M-J, O'Malley BW (1993): Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol Endocrinol 7:1266-1274.
8. Benten WPM, Stephan C, Lieberherr M, Wunderlich F (2001): Estradiol signaling via sequestrable surface receptors. Endocrinology 142:1669-1677.
9. Brady H, Doubleday M, Gayo-Fung LM, Hickman M, Khammungkhune S, Kois A, Lipps S, Pierce S, Richard N, Shevlin G, Sutherland MK, Anderson DW, Bhagwhat SS, Stein B (2002): Differential response of estrogen receptors α and β to SP500263, a novel potent selective estrogen receptor modulator. Mol Pharm 3:562-568.
10. Bramlett KS, Wu Y, Burris TP (2001): Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes. Mol Endocrinol 15:909-922.
11. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engström O, Öhman L, Greene G, Gustafsson J-Å, Carlquist M (1997): Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758.
12. Bunone G, Briand P-A, Miksicek RJ, Picard D (1996): Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174-2183.
13. Burakov D, Wong CW, Rachez C, Cheskis BJ, Freedman LP (2000): Functional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex. J Biol Chem 275:20928-20934.
14. Cenni B, Picard D (1999): Ligand-independent activation of steroid receptors: new roles for old players. TEM 10:41-46.
15. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW (2000): Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87:E44-52.
16. Chandran UR, Warren BS, Baumann CT, Hager GL, DeFranco DB (1999): The glucocorticoid receptor is tethered to DNA-bound Oct-1 at the mouse gonadotropin-releasing hormone distal negative glucocorticoid response element. J Biol Chem 274:2372-2378.
17. Chang C-Y, Norris JD, Grøn H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP (1999): Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors α and β. Mol Cell Biol 19:8226-8239.
18. Cheskis BJ, Karathanasis S, Lyttle CR (1997): Estrogen receptor ligands modulate its interaction with DNA. J Biol Chem 272:11384-11391.
19. Chu S, Fuller PJ (1997): Identification of a splice variant of the rat estrogen receptor β gene. Mol Cell Endocrinol 132:195-199.
20. Collins P, Webb C (1999): Estrogen hits the surface. Nat Med 5:1130-1131.
21. Cowley SM, Hoare S, Mosselman S, Parker MG (1997): Estrogen receptors α and β form heterodimers on DNA. J Biol Chem 272:19858-19862.
22. Cowley SM, Parker MG (1999): A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol 69:165-175.
23. Delaunay F, Pettersson K, Tujague M, Gustafsson J-Å (2000): Functional differences between the amino terminal domains of estrogen receptors α and β. Mol Pharm 58:584-590.
24. El-Tanani MK, Green CD (1997): Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol Endocrinol 11:928-937.
25. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JÅ (1997): Human estrogen receptor β - gene structure, chromosomal localisation and expression pattern. J Clin Endocrinol Met 82:4258-4265.
26. Eriksson MAL, Härd T, Nilsson L (1995): Molecular dynamics simulations of the glucocorticoid receptor DNA-binding domain in complex with DNA and free in solution. Biophys J 68:402-426.
27. Evans RM (1988): The steroid and thyroid hormone superfamily. Science 240:889-895.
28. Filardo EJ, Quinn JA, Bland KI, Frackelton AR (2000): Estrogen-induced activation of erk-1 and erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660.
29. Fuqua SA, Wiltschke C, Zhang QX, Borg A, Castles CG, Friedrichs WE, Hopp T, Hilsenbeck S, Mohsin S, O'Connell P, Allred DC (2000): A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res 60:4026-4029.
30. Galien R, Garcia T (1997): Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Res 25:2424-2429.
31. Gay F, Anglade I, Gong Z, Salbert G (2000): The LIM/Homeodomain protein Islet-1 modulates estrogen receptor functions. Mol Endocrinol 14:1627-1648.
32. Gee AC, Carlson KE, Martini PGV, Katzenellenbogen BS, Katzenellenbogen JA (1999): Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Mol Endocrinol 13:1912-1923.
33. Giguère V (1999): Orphan nuclear receptors: from gene to function. Endocrine Rev 20:689-725.
34. Green S, Walter P, Kumar V, Krust A, Bornert J-M, Argos P, Chambon P (1986): Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134-139.
35. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J (1986): Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150-1154.
36. Greenfield N, Vijayanathan V, Thomas TJ, Gallo MA, Thomas T (2001): Increase in the stability and helical content of estrogen receptor alpha in the presence of the estrogen response element: analysis by circular dichroism spectroscopy. Biochemistry 40:6646-6652.
37. Gu Q, Moss RL (1996): 17 beta-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J Neurosci 16:3620-3629.
38. Hall J, Chang C-Y, McDonnell DP (2000): Development of peptide antagonists that target estrogen receptor β-coactivator interactions. Mol Endocrinol 14:2010-2023.
39. Hall JM, McDonnell DP (1999): The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140:5566-5578.
40. Hall JM, McDonnell DP, Korach KS (2002): Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol Endocrinol 16:469-486.
41. Hanstein B, Liu H, Yancisin M, Brown M (1999): Functional analysis of a novel estrogen receptor-β isoform. Mol Endocrinol 13:129-137.
42. Heery DM, Kalkhoven E, Hoare S, Parker MG (1997): A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733-736.
43. Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA, Korach KS (1996): Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 137:1735-1744.
44. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP (1999): Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 96:4686-4691.
45. Jensen EV, Jacobsen HI (1962): Basic guides to the mechanism of estrogen action. Rec Prog Horm Res 18:387-414.
46. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P (1995): Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494.
47. Katzenellenbogen BS (1996): Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 54:287-293.
48. Katzenellenbogen J, O'Malley BW, Katzenellenbogen BS (1996): Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10:119-131.
49. Kelly MJ, Levin ER (2001): Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12:152-156.
50. Kelly MJ, Wagner EJ (1999): Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol Metab 10:369-374.
51. Kelly MJ, Lagrange AH, Wagner EJ, Ronnekleiv OK (1999): Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64:64-75.
52. Khorasanizadeh S, Rastinejad F (2001): Nuclear-receptor interactions on DNA-response elements. Trends Biochem Sci 26:384-390.
53. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I (1999): Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem Biophys Res Commun 263:257-262.
54. Kraus WL, Kadonaga JT (1998): P300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev 12:331-342.
55. Kraus WL, McInerney EM, Katzenellenbogen BS (1995): Ligand-dependent transcriptionally productive association of the amino- and carboxy-terminal regions of a steroid hormone nuclear receptor. Proc Natl Acad Sci USA 92:12314-12318.
56. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson J-Å (1997): Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870.
57. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-Å (1996): Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930.
58. Kumar R, Baskakov IV, Srinivasan G, Bolen DW, Lee JC, Thompson EB (1999): Interdomain signaling in a two-domain fragment of the human glucocorticoid receptor. J Biol Chem 274:24737-24741.
59. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P (2000): Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317.
60. Lefstin JA, Thomas JR, Yamamoto KR (1994): Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. Genes Dev 8:2842-2856.
61. Leygue E, Dotzlaw H, Lu B, Glor C, Watson PH, Murphy LC (1998): Estrogen receptor β: Mine is longer than yours. J Clin Endocrinol Metab 83:3754-3755.
62. Li C, Briggs MR, Ahlborn TE, Kraemer FB, Liu J (2001): Requirement of Sp1 and estrogen receptor a interaction in 17β-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology 142:1546-1553.
63. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH Jr, Pestell RG, Kushner PJ (2002): Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J Biol Chem 277:24353-24360.
64. Loven MA, Likhite VS, Choi I, Nardulli AM (2001b): Estrogen response elements alter coactivator recruitment through allosteric modulation of estrogen receptor β conformation. J Biol Chem 276:45282-45288.
65. Loven MA, Wood JR, Nardulli AM (2001a): Interaction of estrogen receptors α and β with estrogen response elements. Mol Cell Endocrinol 181:151-163.
66. Mak HY, Hoare S, Henttu PM, Parker MG (1999): Molecular determinants of the estrogen receptor-coactivator interface. Mol Cell Biol 19:3895-3903.
67. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995): The nuclear receptor superfamily: the second decade. Cell 1995;83:835-839.
68. Margeat E, Poujol N, Boulahtouf A, Chen Y, Müller JD, Gratton E, Cavailles V, Royer CA (2001): The human estrogen receptor α dimer binds a single SRC-1 coactivator molecule with an affinity dictated by agonist structure. J Mol Biol 306:433-442.
69. Maruyama K, Endoh H, Sasaki-Iwaoka H, Kanou H, Shimaya E, Hashimoto S, Kato S, Kawashima H (1998): A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regulator of estrogen action. Biochem Biophys Res Comm 246:142-147.
70. Maruyama S, Fujimoto N, Asano K, Ito A (2001): Suppression by estrogen receptor β of AP-1 mediated transactivation through estrogen receptor α. J Steroid Biochem Mol Biol 78:177-184.
71. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW (1995): Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669.
72. McEwen BS (1991): Non-genomic and genomic effects of steroids on neural activity. TIPS 12:141-147.
73. McEwen BS, Alves SE (1999): Estrogen actions in the central nervous system. Endocrine Rev 20:279-307.
74. McInerney -EM, Katzenellenbogen BS (1996): Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J Biol Chem 271:24172-24178.
75. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG (1998b): Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev 12:3357-3368.
76. McInerney EM, Tsai M-J, O'Malley BW, Katzenellenbogen BS (1996): Analysis of estrogen receptor transcriptional enhancement by a nuclear receptor coactivator. Proc Natl Acad Sci USA 93:10069-10073.
77. McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS (1998a): Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras. Endocrinology 139:4513-4522.
78. McKenna NJ, Lanz RB, O'Malley BW (1999): Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344.
79. Mermelstein PG, Becker JB, Surmeier DJ (1996): Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci 16:595-604.
80. Métivier R, Penot G, Flouriot G, Pakdel F (2001): Synergism between ERα transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 α-helical core and for a direct interaction between the N- and C-terminal domains. Mol Endocrinol 15:1953-1970.
81. Métivier R, Petit FG, Valotaire Y, Pakdel F (2000): Function of N-terminal transactivation domain of the estrogen receptor requires a potential α-helical structure and is negatively regulated by the A domain. Mol Endocrinol 14:1849-1871.
82. Métivier R, Stark A, Fluoriot G, Hübner MR, Brand H, Penot G, Manu D, Denger S, Reid G, Kos M, Russell RB, Kah O, Pakdel F, Gannon F (2002): A dynamic structural model for estrogen receptor-α activation by ligands, emphasizing the role of interactions between distant A and E domains. Mol Cell 10:1019-1032.
83. Metzger D, Ali S, Bornert J-M, Chambon P (1995): Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem 270:9535-9542.
84. Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA (1999): Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes. J Med Chem 42:2456-2468.
85. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F (1996): Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996;15:1292-1300.
86. Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS (1996): Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Mol Endocrinol 10:230-242.
87. Montano MM, Muller V, Trobaugh A, Katzenellenbogen BS (1995): The carboxy-terminal F domain of the human estrogen receptor: role of the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol Endocrinol 9:814-825.
88. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su J-L, Kliewer SA, Lehmann JM, Willson TM (1998): Cloning and characterization of human estrogen receptor β isofroms. Biochem Biophys Res Comm 247:75-78.
89. Moras D, Gronemeyer H (1998): The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 10:384-391.
90. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz JL (1992): A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 131:1305-1312.
91. Mosselman S, Polman J, Dijkema R (1996): ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53.
92. Nadal A, Rovira JM, Laribi O, Leon-quinto T, Andreu E, Ripoli C, Soria B (1998): Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor. FASEB J 12:1341-1348.
93. Nilsson S, Gustafsson J-Å (2002): Structure and function of the estrogen receptor. In: Manni A, Verderame MF (eds). Selective Estrogen Receptor Modulators: Research and Clinical Applications. Totowa: Humana Press.
94. Norris JD, Paige LA, Christensen DJ, Chang C-Y, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP (1999): Peptide antagonists of the human estrogen receptor. Science 285:744-746.
95. Ogawa S, Inoue S, Watanabe T, Hiroi H, Orimo A, Hosoi T, Ouchi Y, Muramatsu M (1998a): The complete primary structure of human estrogen receptor β (hERβ) and its heterodimerization with ERα in vivo and in vitro. Biochem Biophys Res Comm 243:122-126.
96. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y, Muramatsu M (1998b): Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor of estrogen action in human. Nucleic Acids Res 26:3505-3512.
97. Onate SA, Boonyaratanakornkit V, Spencer TE, Tsai SY, Tsai MJ, Edwards DP, O'Malley BW (1998): The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem 273:12101-12108.
98. Pace P, Taylor J, Suntharalingam S, Coombes RC, Ali S (1997): Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α. J Biol Chem 272:25832-25838.
99. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-Å, Kushner PJ, Scanlan TS (1997): Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510.
100. Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM (1999): Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Nat Acad Sci USA 96:3999-4004.
101. Pappas TC, Gametchu B, Watson CS (1995): Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 9:404-410.
102. Petersen DN, Tkalcevic GT, Koza-Taylor PH, Turi TG, Brown TA (1998): Identification of estrogen receptor β2, a functional variant of estrogen receptor β expressed in normal rat tissues. Endocrinology 139:1082-1092.
103. Pettersson K, Delaunay F, Gustafsson J-Å (2000): Estrogen receptor β acts as a dominant regulator of estrogen signalling. Oncogene 19:4970-4978.
104. Pettersson K, Grandien K, Kuiper GGJM, Gustafsson J-Å (1997): Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol Endocrinol 11:1486-1496.
105. Pike ACW, Brzozowski AM, Hubbard RE, Bonn T, Thorseli A-G, Engström O, Ljunggren J, Gustafsson J-Å, Carlquist M (1999): Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18:4608-4618.
106. Pike ACW, Brzozowski AM, Walton J, Hubbard RE, Thorsell A-G, Li Y-L, Gustafsson J-Å, Carlquist M (2001): Structural insights into the mode of action of a pure antiestrogen. Structure 9:145-153.
107. Porter W, Saville B, Hoivik D, Safe S (1997): Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569-1580.
108. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW (1991): Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254:1636-1639.
109. Qin C, Singh P, Safe S (1999): Transcriptional activation of insulin-like growth factor-binding protein-4 by 17β-estradiol in MCF-7 cells: role of estrogen receptor-SP1 complexes. Endocrinology 140:2501-2508.
110. Quaedackers ME, Van Den Brink CE, Wissink S, Schreurs RH, Gustafsson J-Å, Van Der Saag PT, Van Der Burg BB (2001): 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta. Endocrinology 142:1156-1166.
111. Rastinejad F, Wagner T, Zhao Q, Khorasanizadeh S (2000): Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J 19:1045-1054.
112. Ray A, Prefontaine KE, Ray P (1994: Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 269:12940-12946.
113. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER (2002): ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16:100-115.
114. Razandi M, Pedram A, Greene GL, Levin ER (1999): Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307-319.
115. Revelli A, Massobrio M, Tesarik J (1998): Nongenomic actions of steroid hormones in reproductive tissues. Endocrine Rev 19:3-17.
116. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson J-Å, Safe S (2000): Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275:5379-5387.
117. Schwabe JWR, Chapman L, Finch JT, Rhodes D (1993): The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75:567-578.
118. Schwabe JWR, Chapman L, Rhodes D (1995): The oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation. Structure 3:201-213.
119. Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, Carriere C, Rose DW, Hooshmand F, Aggarwal AK, Rosenfeld MG (2000): Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 290:1127-1131.
120. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M (2000): Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
121. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL (1998): The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937.
122. Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL (2002): Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol 9:359-364.
123. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O'Malley BW (1997): Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52:141-165.
124. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM (1999): The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19:2455-2463.
125. Stein B, Yang MX (1995): Repression of the interleukin-6 promoter by estrogen receptor is mediated by NFκB and C/EBPβ. Mol Cell Biol 15:4971-4979.
126. Stevis PE, Deecher DC, Suhadolnik L, Mallis LM, Frail DE (1999): Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 140:5455-5458.
127. Suen CS, Berrodin TJ, Mastroeni R, Cheskis BJ, Lyttle CR, Frail DE (1998): A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J Biol Chem 273:27645-27653.
128. Sun G, Porter W, Safe S (1998): Estrogen-induced retinoic acid receptor α1 gene expression: role of estrogen receptor-Sp1 complex. Mol Endocrinol 12:882-890.
129. Sutter-Dub M-T (2002): Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte and other cell types. Steroids 67:77-93.
130. Takeshita A, Yen PM, Ikeda M, Cardona GR, Liu Y, Koibuchi N, Norwitz ER, Chin WW (1998): Thyroid hormone response elements differentially modulate the interactions of thyroid hormone receptors with two receptor binding domains in the steroid receptor coactivator-1. J Biol Chem 273:21554-21562.
131. Takeyama K, Masuhiro Y, Fuse H, Endoh H, Murayama A, Kitanaka S, Suzawa M, Yanagisawa J, Kato S (1999): Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog. Mol Cell Biol 19:1049-1055.
132. Teyssier C, Belguise K, Galtier F, Chalbos D (2001): Characterization of the physical interaction between estrogen receptor α and jun proteins. J Biol Chem 276:36361-36369.
133. Todo T, Adachi S, Yamauchi K (1996): Molecular cloning and characterization of Japanese eel estrogen receptor cDNA. Mol Cell Endocrinol 119:37-45.
134. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguère V (1997): Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol Endocrinol 11:352-365.
135. Tremblay A, Tremblay GB, Labrie F, Giguère V (1999a): Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1. Mol Cell 3:513-519.
136. Tremblay GB, Tremblay A, Labrie F, Giguere V (1999b): Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex. Mol Cell Biol 19:1919-1927.
137. Umesono K, Evans. RM (1989): Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57:1139-1146.
138. Valentine JE, Kalkhoven E, White R, Hoare S, Parker MG (2000): Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression. J Biol Chem 275:25322-25329.
139. van Tilborg MA, Lefstin JA, Kruiskamp M, Teuben J, Boelens R, Yamamoto KR, Kaptein R (2000): Mutations in the glucocorticoid receptor DNA-binding domain mimic an allosteric effect of DNA. J Mol Biol 301:947-958.
140. Wang W, Dong L, Saville B, Safe S (1999): Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol Endocrinol 13:1373-1387.
141. Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT, Albanese C, Lisanti MP, Katzenellenbogen BS, Kato S, Hopp T, Fuqua SAW, Lopez GN, Kushner PJ, Pestell RG (2001): Direct acetylation of the estrogen receptor α hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem 276:18375-18383.
142. Wärnmark A, Treuter E, Gustafsson J-Å, Hubbard RE, Brzozowski AM, Pike AC (2002): Interaction of TIF2 NR-box peptides with the coactivator binding site of ERalpha. J Biol Chem 277:21862-21868.
143. Watson CS, Pappas TC, Gametchu B (1995): The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens. Environ Health Perspect 103 (Suppl 7):41-50.
144. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM (1997): Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138:4030-4033.
145. Watters JJ, Dorsa DM (1998): Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms. J Neurosci 18:6672-6680.
146. Webb P, Lopez GN, Uht RM, Kushner PJ (1995): Tamoxifen activation of the estrogen receptor/AP1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456.
147. Webb P, Nguyen P, Shinsako J, Anderson C, Feng W, Nguyen MP, Chen D, Huang SM, Subramanian S, McKinerney E, Katzenellenbogen BS, Stallcup MR, Kushner PJ (1998): Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol Endocrinol 12:1605-1618.
148. Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson J-Å, Nilsson S, Kushner PJ (1999): The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 13:1672-1685.
149. Weigel NL, Zhang Y (1998): Ligand-independent activation of steroid hormone receptors. J Mol Med 76:469-479.
150. Wong C-W, Komm B, Cheskis BJ (2001): Structure-function evaluation of ERα and β interplay with SRC family coactivators. ER selective ligands. Biochemistry 40:6756-6765.
151. Wood JR, Likhite VS, Loven MA, Nardulli AM (2001): Allosteric modulation of estrogen receptor conformation by different estrogen response elements. Mol Endocrinol 15:1114-1126.
152. Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM, Shaul PW (2001): Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Gα. J Biol Chem 276:27071-27076.
153. Zhou Y, Watters JJ, Dorsa DM (1996): Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137:2163-2166.
154. Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto E (1999): Estrogen receptor β activates the human retinoic acid receptor α-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen. Mol Endocrinol 13:418-430.